When first-line treatments fail, should clozapine be considered for severe aggression in autistic youth? A retrospective chart review suggests reduced hospital visits and meaningful clinical improvement in carefully monitored patients. We review who might benefit—and how to balance efficacy with safety and monitoring demands.